Table 3.

Efficacy of molnupiravir based on the MOVe-OUT trial

Treatment effect	Risk ratio [confidence interval]
Progression to COVID-19 related hospitalization	0.69 [0.48–1.00]
Progression to score 6 (ICU)	0.83 [0.33–2.08]
Progression to scores 7–9 (mechanical ventilation)	0.76 [0.24–2.37]

Note: Estimates are derived from post hoc analysis of MOVe-OUT trial data through day 29 (see Supplementary information Table 11).

ICU intensive care unit, WHO World Health Organization